
Quest Diagnostics Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

I'm PortAI, I can summarize articles.
Quest Diagnostics Inc. stock rose 1.15% to $181.57 on Thursday, ending a four-day losing streak, but underperformed compared to competitors like UnitedHealth Group, IQVIA Holdings, and Centene Corp. Despite gains, it remains 8.09% below its 52-week high. Trading volume was below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

